References
- Winslow R. M. Hemoglobin-based red cell substitutes: unsolved issues and future directions. Artificial Red Cells, E. Tsuchida, 1995; 17–130
- Rudolph A. S. Encapsulated hemoglobin: current issues and future goals. Art. Cells. Blood Subs, and Immob. Biotech. 1994; 22: 347–760
- Rudolph AS., Klipper R. W., Goins B., Phillips W. T. In vivo biodistribution of a radiolabeled blood substitutes: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. Proc. Natl. Acad. Sci. USA 1991; 88: 10976–10980
- Langdale L. A., Maier R. V., Wilson L., Pohlman T. H., Williams L. G., Rice C. L. Liposome-encapsulated hemoglobin inhibits tumor necrosis factor release from rabbit alveolar macrophages by a posttranscriptional mechanism. J. Leukoc. Biol. 1992; 52: 679–686
- Rudolph A. S., Cliff R. O., Spargo B. J., Spielberg H. Transient changes in the mononuclear phagocyte system following administration of the blood substitute liposome-encapsulated haemoglobin. Biomaterials 1994; 15: 796–804
- Bankey P., Beecherl E., Bibus D., See D., McIntyre K. Liposomes modulate Kupffer cell endotoxin response. Arch. Surg. 1995; 130: 1266–1272
- Rollwagen F. M., Gafney W. C.M., Pacheco N. D., Davis T. A., Hickey T. M., Nielsen T. B., Rudolph A. S. Multiple responses to administration of liposome-encapsulated hemoglobin (LEH): Effects on hematopoiesis and IL-6 levels. Exp. Hematol. 1996; 24: 429–436
- Rudolph A. S., Cliff R., Kwasiborski V., Neville L., Abdullah F., Rabinovici R. Liposome-encapsulated hemoglobin modulates lipopolysaccharide-induced tumor necrosis factor-alpha production in mice. Crit. Care Med. 1997; 25: 460–468
- Zhu X.-L., Gafney W.C.M., Pacheco N. D., Rollwagen F. M. Kinetics of cytokine gene expression in macrophage and endothelial cell lines following liposome encapsulated haemoglobin (LEH) treatment in vitro. Cytokine 1996; 8: 541–547
- Nerad J. L., Griffiths J. K., Van der Meer J.W.M., Endres S., Poutsiaka D. D., Keusch G. T., Bennish M., Salam M. A., Dinarello C. A., Cannon J. G. Interleukin-ip (IL-ip), IL-1 receptor antagonist, and TNF-a production in whole blood. J. Leukoc. Biol. 1992; 52: 687–692
- Bouma M. G.T., Jeunhomme M. M.A., Boyle D. L.MA., Dentener N. N., Voitenok F. A.J., van den Wildenberg M., Buurman W. A. Adenosine inhibits nentrophil degranulation in activated human whole blood. J. Immunol. 1997; 158: 5400–5408
- Szebeni J., Wassef N. M., Hartman K. R., Rudolph A. S., Alving C. R. Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: Mechanism of activation and inhibition by soluble complement receptor type 1. Transfusion 1997; 37: 150–159
- Bitterman H., Kinarty A., Lazarovich H., Lahat N. Acute release of cytokines is proportional to tissue injury induced by surgical trauma and shock in rats. J. Clin. Immunol. 1991; 11: 184–192
- Damas P., Ledoux D., Nys M., Vrindts Y., De Groote D., Franchimont P., Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 1992; 215: 356–362
- Oka Y., Murata A., Nishijima J., Yasuda T., Hiraoka N., Ohmachi Y. K., Kitagawa Yasuda T., Toda H., Tanaka N., Mori T. Circulating interleukin 6 as a useful marker for predicting postoperative complications. Cytokine 1992; 4: 298–304